Clinical studies management and support (csms)
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00028
- Awardee
-
Navitas Clinical Research Inc. UEI HA8KGRBJZNM8
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,238,413
Award facts
- Opportunity
-
- Clinical Studies Management and Support (CSMS) Pre-Solicitation · 75N92021R0034 · Posted May 21, 2021
- Contract value 100% obligated
-
- $8,238,413.00 Current, with exercised options
- $8,254,903.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Insititue of Arthritis and Musculoskeletal and Skin Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$68 | |
| Additional Work (new agreement, FAR part 6 applies) | $790,981 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $2,666,989 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $15,825 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,443,691 | |
| Funding Only Action | $45,341 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,275,654 |
Show all 12
About this award
The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded an $8.25 million definitive contract to Navitas Clinical Research Inc. for clinical studies management and support on September 30, 2021, under a sole-source bridge contract. The contract completed on January 24, 2025.
The originating solicitation, posted May 21, 2021, covers clinical research management, oversight, and operations support for studies funded by the institute. Specific deliverables include risk-based monitoring of selected clinical studies, statistical review and consultation, training and education of NIH staff and investigators, and maintenance of electronic systems including a clinical studies database. Place of performance is North Bethesda, MD.
Under firm fixed price terms, Navitas invoiced $2.3 million in FY2022 (10.8 FTEs, 22,534 contractor hours), $2.4 million in FY2023 (11.2 FTEs, 23,224 contractor hours), and $2.7 million in FY2024. The derived government-paid hourly rate was $103.00 in FY2022 and $105.08 in FY2023. The contractor self-performed all reported hours across the contract term with no subcontractors.
Quick answers
Who was awarded contract 75N92021C00028?
75N92021C00028 was awarded to Navitas Clinical Research Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 30, 2021.
How much is contract 75N92021C00028 worth?
The government has obligated $8,238,413 on 75N92021C00028. Its potential value, with all options, is $8,254,903.
Which agency awarded contract 75N92021C00028?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92021C00028, with funding from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health).
Was contract 75N92021C00028 competed?
The extent of competition for 75N92021C00028 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award